US Broker Ratings

ResMed Inc. (RMD) Stock Analysis: Unveiling a 19.19% Potential Upside for Investors

ResMed Inc. (NYSE: RMD), a leading player in the healthcare sector specializing in medical instruments and supplies, continues to capture investor attention with its robust market..

Sanofi (SNY) Stock Analysis: A 23% Upside Potential Amid Robust Dividend Yield

Sanofi (NASDAQ: SNY), a titan in the healthcare sector, stands out with a market capitalization of $116.85 billion, positioning itself as a formidable player in the..

Johnson & Johnson (JNJ) Stock Analysis: Balancing Healthcare Innovation with Steady Returns

Johnson & Johnson (NYSE: JNJ), a titan in the healthcare sector, continues to demonstrate its robust presence in the drug manufacturing industry, boasting a market capitalization..

DexCom, Inc. (DXCM) Investor Outlook: Unlocking a Potential 28% Upside in the Healthcare Sector

DexCom, Inc. (NASDAQ: DXCM), a leader in the continuous glucose monitoring (CGM) market, continues to make waves in the healthcare sector with its innovative medical devices...

Amgen Inc. (AMGN) Stock Analysis: Navigating Growth and Stability with a 2.95% Dividend Yield

Amgen Inc. (NASDAQ: AMGN) stands out in the healthcare sector as a global leader in biotechnology, delivering a diverse array of human therapeutics. With a market..

Danaher Corporation (DHR) Stock Analysis: Evaluating a Strong Buy with 12.51% Upside Potential

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, continues to capture the attention of investors with a market capitalization of $164.98 billion. Operating..

Eli Lilly and Company (LLY) Stock Analysis: Exploring the Robust Growth Potential and Analyst Consensus

Eli Lilly and Company (NYSE: LLY), a stalwart in the healthcare sector, particularly in drug manufacturing, continues to capture investor attention with its impressive financial metrics..

Bristol-Myers Squibb (BMY) Stock Analysis: Navigating Potential Upside in Healthcare Giants

Bristol-Myers Squibb Company (NYSE: BMY), a titan in the biopharmaceutical industry, is attracting investor attention with its robust product offerings and promising growth metrics. With a..

AstraZeneca PLC (AZN) Stock Analysis: A Healthcare Giant with 8% Upside Potential

For investors eyeing the healthcare sector, AstraZeneca PLC (NASDAQ: AZN) presents a compelling opportunity. As a prominent player in the drug manufacturing industry, this UK-based biopharmaceutical..

Medtronic plc (MDT) Stock Analysis: Navigating a 15.53% Upside Potential in the Dynamic Medical Devices Sector

Medtronic plc (MDT), a titan in the medical devices industry, continues to capture investor interest with its robust portfolio and strategic positioning within the healthcare sector...

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Navigating Growth with a 7.91% Upside Potential

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, particularly within the diagnostics and research industry, continues to capture investor attention with its..

Abivax SA (ABVX) Stock Analysis: A Biotech Powerhouse with 7.75% Potential Upside

Investors with a keen eye for the biotechnology sector may want to turn their attention to Abivax SA (ABVX), a French clinical-stage biotech firm that is..

Kamada Ltd. (KMDA) Stock Analysis: Unearthing an 84% Upside Potential in the Healthcare Sector

Kamada Ltd. (NASDAQ: KMDA), an Israeli healthcare company specializing in plasma-derived protein therapeutics, is currently making waves in the drug manufacturing industry with a striking potential..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 50% Upside Potential with Analyst Confidence

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector, is catching the attention of investors, particularly due to its impressive potential upside. With a..

Autolus Therapeutics plc (AUTL): Analyst Optimism with a 384% Potential Upside

Autolus Therapeutics plc (NASDAQ: AUTL), a UK-based biotechnology firm, is gaining attention from investors with a significant potential upside of 384.09%. Specializing in the development of..

COMPASS Pathways (CMPS): Potential 143% Upside as Psilocybin Therapy Nears Key Milestones

COMPASS Pathways Plc – American (CMPS), a trailblazer in the mental health sector, has captured the attention of investors with a compelling upside potential of 143.74%...

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: Exploring a 155.71% Potential Upside in the Biotech Sector

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC) presents an intriguing opportunity within the biotechnology sector, boasting a market capitalization of $796.64 million. As a clinical-stage biopharmaceutical company, Oric..

MeiraGTx Holdings plc (MGTX)

⚠️ No article content returned.

..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Uncovering a 9.22% Potential Upside Amidst Strategic Healthcare Endeavors

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector, specializes in providing critical preparedness and response solutions for various public health threats. With..

Arvinas, Inc. (ARVN) Stock Analysis: Navigating the Biotechnology Frontier with PROTAC Innovation

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company, stands at the forefront of pioneering therapies that leverage the body’s natural mechanisms to target and degrade disease-causing..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds